ASN
STRO icon

Advisory Services Network’s Sutro Biopharma STRO Stock Holding History

Advisory Services Network’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$374 Buy
+15
New +$271 ﹤0.01% 4470
2025
Q4 		– Sell
-15
Closed -$128 – 3961
2025
Q3 		$128 Buy
+15
New +$128 ﹤0.01% 4292

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Advisory Services Network's STRO Position: Q1 2026 in Review

Advisory Services Network opened a new position in Sutro Biopharma (STRO) in Q1 2026: 15 shares worth $374. The stake represents ﹤0.01% of the portfolio and ranks #4470 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in STRO as recently as Q3 2025.

Advisory Services Network first reported a position in STRO in Q3 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Advisory Services Network held 15 shares of Sutro Biopharma worth $374 as of Q1 2026.
  • Sutro Biopharma was a new Advisory Services Network position in Q1 2026.
  • Sutro Biopharma made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4470 holding.
  • Advisory Services Network first reported a position in Sutro Biopharma in Q3 2025 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.